Test of Allergan baldness remedy under way

This phase of the trials will include a total of about 28 patients — men with moderate male-pattern baldness and women with moderate female-pattern hair loss

Dec 2010

Botox maker Allergan has begun clinical trials of a possible hair-growth treatment based on the active ingredient in its drug Latisse, which stimulates the growth of eyelashes.

Allergan announced late last month on the federal Clinical Trials website that recruiting of volunteer subjects has begun. This phase of the experiments is scheduled to be completed in February.

The website includes a description of what’s required of volunteers and an email address for more information.

The experimenters aren’t in a location that’s convenient to Orange County: They are in Tempe, Ariz.

This phase of the trials will include a total of about 28 patients — men with moderate male-pattern baldness and women with moderate female-pattern hair loss.

The FDA approved Latisse in 2008 as a treatment for sparse eyelashes, with a warning that it can cause hair growth on other parts of the body that come in contact with the drug. Some doctors have already tried using Latisse as an “off-label” treatment for hair loss.

Source